Similar articles

• BCL-6 in diffuse large-cell lymphomas.

  Dalla-Favera R, Ye BH, Cattoretti G, Lo Coco F, Chang CC, Zhang J, Migliazza A, Cechova K, Niu H, Chaganti S, Chen W, Louie DC, Offit K, Chaganti RS. Dalla-Favera R, et al. Important Adv Oncol. 1996:139-48. Important Adv Oncol. 1996. PMID: 8791133 Review. No abstract available.
• The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.

  Deweindt C, Albagli O, Bernardin F, Dhordain P, Quief S, Lantoine D, Kerckaert JP, Leprince D. Deweindt C, et al. Cell Growth Differ. 1995 Dec;6(12):1495-503. Cell Growth Differ. 1995. PMID: 9019154
• The proto-oncogene BCL-6 in normal and malignant B cell development.

  Niu H. Niu H. Hematol Oncol. 2002 Dec;20(4):155-66. doi: 10.1002/hon.689. Hematol Oncol. 2002. PMID: 12469325 Review.
• Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease.

  Pescarmona E, Lo Coco F, Pacchiarotti A, Rapanotti MC, Cimino G, Di Paolo B, Baroni CD. Pescarmona E, et al. J Pathol. 1995 Sep;177(1):21-5. doi: 10.1002/path.1711770105. J Pathol. 1995. PMID: 7472775
• BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas.

  Pittaluga S, Ayoubi TA, Wlodarska I, Stul M, Cassiman JJ, Mecucci C, Van Den Berghe H, Van De Ven WJ, De Wolf-Peeters C. Pittaluga S, et al. J Pathol. 1996 Jun;179(2):145-50. doi: 10.1002/(SICI)1096-9896(199606)179:2<145::AID-PATH565>3.0.CO;2-1. J Pathol. 1996. PMID: 8758205